John Theurer Cancer Center at Hackensack University Medical Center ( Site 0005)

Hackensack, New Jersey 07601

0 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Neoplasms, Urinary Bladder Neoplasms

Studies at this site

• Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) — Running, not enrolling
• Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) — Completed
• Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001) — Completed